Anti-NMDA-receptor encephalitis and MOGAD associated optic neuritis: a case series - Report - MDSpire

Anti-NMDA-receptor encephalitis and MOGAD associated optic neuritis: a case series

  • By

  • Pooja Parthasarathi

  • Michael Dattilo

  • Jason Peragallo

  • July 10, 2026

  • 0 min

Share

Clinical Report: A Case Series of Optic Neuritis in Patients with Anti-NMDA-Receptor Encephalitis and MOGAD

Background

Anti-NMDAR encephalitis is an autoimmune disorder characterized by neuropsychiatric symptoms and seizures, while MOGAD is associated with optic neuritis. The co-occurrence of these conditions is increasingly recognized.

Data Highlights

PatientAgeInitial SymptomsTreatmentVisual Acuity Outcome
136Altered mental status, vision lossIV steroids, PLEX, rituximabImproved to baseline
226Altered mental status, vision lossIV steroids, PLEX, rituximabImproved to baseline
319Headache, vision lossIV steroids, IVIG, tocilizumabImproved to baseline

Key Findings

  • All patients tested positive for CSF anti-NMDAR antibodies during the encephalitis episode.
  • Positive serum MOG titers were found during the optic neuritis episode in all cases.
  • Patients presented with bilateral, asymmetrically reduced visual acuity and diminished color vision.
  • Imaging revealed abnormal T2/FLAIR lesions and optic nerve enhancement.
  • Visual acuity improved to baseline levels following treatment in all patients.

Clinical Implications

Patients with anti-NMDAR encephalitis may develop optic neuritis, which can occur months to years after the initial encephalitis.

Conclusion

This case series highlights the overlap between anti-NMDAR encephalitis and MOGAD optic neuritis.

Related Resources & Content

  1. Frontiers in Immunology, 2026 -- Triple antibody-associated autoimmune encephalitis overlap: a case report of co-existing MOG-IgG, anti-NMDAR, and anti-mGluR5 positivity
  2. Frontiers in Immunology, 2026 -- Myelin oligodendrocyte glycoprotein antibody-associated disease presenting as encephalitis and concurrent Epstein-Barr virus detection: a case series
  3. Frontiers in Immunology, 2026 -- Anti-NMDAR and anti-MOG antibody double-positive encephalitis temporally associated with cytomegalovirus detection in cerebrospinal fluid: a case report
  4. PubMed, 2023 -- Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria
  5. Canadian Consensus Guidelines for the Diagnosis and Treatment of Autoimmune Encephalitis in Adults, 2024
  6. Frontiers in Immunology — Case Report: Pediatric MOG/NMDAR overlap syndrome with delayed cortical MRI evolution and incidental venous sinus hypoplasia
  7. Efficacy and comparison of corticosteroids only and corticosteroids with plasmapheresis or intravenous immunoglobulin for the treatment of optic neuritis in demyelinating disease: A systematic review and network meta-analysis
  8. Optic neuritis: a comprehensive review of current therapies and emerging treatment strategies
  9. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria - PubMed
  10. Canadian Consensus Guidelines for the Diagnosis and Treatment of Autoimmune Encephalitis in Adults
  11. Anti-N-methyl-d-aspartate receptor encephalitis: insights and future treatment directions - PubMed
  12. A Phase-2B Double-Blind Randomized International Prospective Trial of Inebilizumab in NMDAR Encephalitis: The ExTINGUISH Trial | Neurology Open Access
  13. Latin American RAND/UCLA modified Delphi consensus recommendations for management and treatment of adult MOGAD patients in clinical practice - PubMed
  14. The spectrum of overlapping anti-NMDAR encephalitis and demyelinating syndromes: a systematic review of presentation, diagnosis, management, and outcomes - PubMed
  15. Structural and functional biomarkers of visual dysfunction in MOG antibody-positive optic neuritis: a scoping review - PubMed

Original Source(s)

Related Content